A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder

Clinical trial NCT04338321 · COMPLETED

Trial details

NCT number: NCT04338321
Sponsor: Janssen-Cilag International NV
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Depressive Disorder, Major

Start date: 2020-08-21
Primary completion: 2022-01-20
Enrollment: 676

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.